| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0007 |